Search details
1.
Anxiety and dysautonomia symptoms in patients with a NaV1.7 mutation and the potential benefits of low-dose short-acting guanfacine.
Clin Auton Res
; 34(1): 191-201, 2024 02.
Article
in English
| MEDLINE | ID: mdl-38064009
Results
1 -
1
de 1
1
Next >
>>